AstraZeneca
AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Some of the key events about AstraZeneca
- 1913The company was founded as Astra AB in Södertälje, Sweden
- 1999Astra AB merged with Zeneca Group to form AstraZeneca
- 1999Paid $355 million to settle allegations of Medicare fraud
- 2003Faced criticism for allegedly suppressing negative clinical trial data for the antidepressant Seroquel
- 2004Launched Crestor, a highly effective cholesterol-lowering drug
- 2007Acquired MedImmune, expanding its biologics and vaccines capabilities
- 2010Paid $520 million to settle allegations of off-label marketing of the antipsychotic drug Seroquel
- 2011Received FDA approval for Brilinta, a blood-thinning medication for acute coronary syndromes
- 2011Agreed to pay $68.5 million to settle allegations of deceptive marketing practices for Seroquel
- 2013Faced accusations of bribing doctors in China to boost drug sales
- 2014Successfully fended off a takeover attempt by Pfizer, maintaining its independence
- 2014Paid $110 million to settle allegations of violating the Foreign Corrupt Practices Act in multiple countries
- 2015Acquired ZS Pharma, strengthening its cardiovascular and metabolic disease portfolio
- 2016Agreed to pay $5.5 million to resolve allegations of violating a previous corporate integrity agreement
- 2019Launched Calquence for the treatment of chronic lymphocytic leukemia
- 2020Developed a COVID-19 vaccine in collaboration with Oxford University
- 2020Faced criticism for delays and supply shortages in COVID-19 vaccine production for the European Union
- 2021Acquired Alexion Pharmaceuticals, expanding into rare disease treatments
- 2021Several European countries temporarily suspended use of AstraZeneca's COVID-19 vaccine due to blood clot concerns
- 2021Criticized for selling its stake in Moderna for $1 billion before the COVID-19 pandemic, missing out on larger gains
Disclaimer: This material is written based on information taken from open sources, including Wikipedia, news media, podcasts, and other public sources.
AstraZeneca Latest news
Popular
New Syrian leader reveals empty coffers as dollar hits 35,000 pounds
Lithuanian defense chief warns: Europe must pay its fair share for protection
Trump's unexpected trade strategy leaves world markets guessing what's next
Biden talks big money and future of women's health at White House meeting
